This inventor holds 3 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Innovator Spotlight: Nelly Corine Moore from Macclesfield, GB
Introduction: Nelly Corine Moore is an accomplished inventor based in Macclesfield, Great Britain. With a keen focus on innovation in the pharmaceutical field, she has successfully secured three patents that demonstrate her contributions to medical science.
Latest Patents: Among her notable inventions are quinazoline compounds, which have shown therapeutic uses. Her recent patents include:
1. **Quinazoline compounds with therapeutic use** - This invention pertains to the use of quinazoline derivatives of Formula (I) for the manufacture of a medicament aimed at preventing or treating T cell mediated diseases or medical conditions in warm-blooded animals.
2. **Quinazoline derivatives for the treatment of T cell mediated diseases** - This patent concerns the same class of quinazoline derivatives, focusing on their application in developing medications for similar medical conditions.
Career Highlights: Nelly is currently employed by AstraZeneca AB, a leading global biopharmaceutical company. Her work here emphasizes the development of innovative treatments that can address significant health challenges.
Collaborations: Throughout her career, Nelly has had the opportunity to collaborate with her esteemed coworker, Keith Oldham. Their partnership has fostered an environment of creativity and problem-solving, leading to significant advancements in their field.
Conclusion: Nelly Corine Moore's innovative spirit and dedication to research exemplify the impact that a single inventor can have on the world of medicine. Her work in developing quinazoline compounds is a testament to the ongoing fight against diseases and the vital role of invention in healthcare.